Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies

Patients with hematological malignancies have high risk for morbidity and mortality from influenza. This study was conducted to evaluate the immunogenicity and reactogenicity of an influenza A(H1N1)pdm09 vaccine among such subjects. Fifty subjects were vaccinated twice during the 2009–2010 season. T...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Ide, Yuichiro, Imamura, Yutaka, Ohfuji, Satoko, Fukushima, Wakaba, Ide, Saburo, Tsutsumi, Chiyo, Koga, Masahisa, Maeda, Kazuhiro, Hirota, Yoshio
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896784/
https://ncbi.nlm.nih.gov/pubmed/25424946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29094
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars